Children vaccinated against hepatitis B might be at a lower risk of developing leukemia, according to a new study.

Researchers at Université du Québec à Montréal  have identified a gene that may improve the diagnosis of B-cell acute lymphocytic leukemia, the most prevalent leukemia in children younger than 20 years of age.